Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Balaglitazone Efficacy and Safety in Type 2 Diabetes on Insulin
NCT00515632Phase 3Completed
- Sponsor
- Rheoscience
- Start
- Jul 2007
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of balaglitazone in type 2 diabetes mellitus (T2DM), sponsored by Rheoscience. Started Jul 2007; status: completed.
02
Drugs
balaglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00515632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00515632.